Marion E. Morrison

729 citations

16 papers · 526 indexed · h-index 9

Impact in

Virology top 5%
- Poxvirus research and outbreaks
Epidemiology top 10%
- Herpesvirus Infections and Treatments
- Cytomegalovirus and herpesvirus research

Papers in ⓘ

Epidemiology 7
- Cytomegalovirus and herpesvirus research 4
- Herpesvirus Infections and Treatments 2
Oncology 6
- Drug Transport and Resistance Mechanisms 3
- Polyomavirus and related diseases 2

Co-authors: Thomas M. Brundage (6 shared papers)Greg Chittick (2 shared papers)W. Garrett Nichols (2 shared papers)Roy F. Chemaly (3 shared papers)Herve Momméja-Marin (3 shared papers)Michael Boeckh (2 shared papers)Tsiporah B. Shore (2 shared papers)Timothy K. Tippin (1 shared paper)
Journals: Biology of Blood and Marrow Transplantation (3 papers)Open Forum Infectious Diseases (2 papers)The Journal of Clinical Pharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)Therapeutic Drug Monitoring (1 paper)
Partner nations: United States South Korea United Kingdom

In The Last Decade

Marion E. Morrison

16 papers receiving 501 citations

Peers

Countries citing papers authored by Marion E. Morrison

Since Specialization

Citations

This map shows the geographic impact of Marion E. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion E. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion E. Morrison more than expected).

Fields of papers citing papers by Marion E. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion E. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion E. Morrison. The network helps show where Marion E. Morrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Marion E. Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marion E. Morrison Line = papers co-authored together Marion E. Morrison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Francisco M. Marty, Drew J. Winston, Roy F. Chemaly, Kathleen M. Mullane, Tsiporah B. Shore, Genovefa A. Papanicolaou, Greg Chittick, Thomas M. Brundage, Thad E. Wilson, Marion E. Morrison, Scott A. Foster, W. Garrett Nichols, Michael Boeckh	2018	157
2	Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial Biology of Blood and Marrow Transplantation ·Michael Grimley, Roy F. Chemaly, Janet A. Englund, Joanne Kurtzberg, Gregory E. Chittick, Thomas M. Brundage, Andrew Bae, Marion E. Morrison, Vinod K. Prasad	2017	118
3	Short-term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox Antiviral Research ·Greg Chittick, Marion E. Morrison, Thomas M. Brundage, W. Garrett Nichols	2017	96
4	Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies Therapeutic Drug Monitoring ·Timothy K. Tippin, Marion E. Morrison, Thomas M. Brundage, Herve Momméja-Marin	2016	58
5	Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial Biology of Blood and Marrow Transplantation ·Francisco M. Marty, Drew J. Winston, Roy F. Chemaly, Michael Boeckh, Kathlene M. Mullane, Tsiporah B. Shore, Genovefa A. Papanicolaou, Marion E. Morrison, Thomas M. Brundage, Herve Momméja-Marin	2016	29
6	Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial. PubMed ·Steven Mm, Marion E. Morrison, Sturrock Rd	1985	21
7	Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19 Advances in Therapy ·Joseph A. Lasky, Jyotsna Fuloria, Marion E. Morrison, Randall Lanier, Odin Naderer, Tom Brundage, Allen S. Melemed	2020	13
8	Establishment of the 1st International Genetic Reference Panel for Factor V Leiden, human gDNA Thrombosis and Haemostasis ·J. Ross Hawkins, Marion E. Morrison, Malcolm Hawkins, Ed Byrne, Steve Kitchen, Ian Jennings, Michael Makris, F E Preston, Paul Metcalfe, Elaine Gray	2006	10
9	Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects Open Forum Infectious Diseases ·Mary Beth Wire, Marion E. Morrison, M. Anderson, Thangam Arumugham, John A. Dunn, Odin Naderer	2017	8
10	A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects Clinical Pharmacology in Drug Development ·Shamia L. Faison, Joëlle Batonga, Thangam Arumugham, Angela Bartkus, Marion E. Morrison, Mark J. Mullin, Tim Tippin, Odin Naderer	2025	4
11	A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults British Journal of Clinical Pharmacology ·Shamia L. Faison, Joëlle Batonga, Thangam Arumugham, Angela Bartkus, Marion E. Morrison, Mark J. Mullin, Tim Tippin, Odin Naderer	2025	3
12	Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co‐Administration of the Proton‐Pump Inhibitor Rabeprazole The Journal of Clinical Pharmacology ·Shamia L. Faison, Joëlle Batonga, Thangam Arumugham, Angela Bartkus, Marion E. Morrison, Mark J. Mullin, Tim Tippin, Odin Naderer	2024	2
13	1421. IV Brincidofovir (BCV): Pharmacokinetics (PK) and Safety of Multiple Ascending Doses (MAD) in Healthy Subjects Open Forum Infectious Diseases ·Odin Naderer, Virna Schuck, Marion E. Morrison, M. Anderson, Thangam Arumugham, John A. Dunn	2018	2
14	Switch From Existing Antivirals to Brincidofovir Leads to Improving Renal Function. Transplantation ·Marion E. Morrison, Robert L. Avery, E. L. Kwak, Thomas M. Brundage, Herve Momméja-Marin	2014	2
15	A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants Clinical Pharmacology in Drug Development ·Yohannes Teffera, Tim Tippin, Angela Bartkus, Francine Attié de Castro, Shamia L. Faison, Marion E. Morrison, Mark J. Mullin, Odin Naderer	2025	2
16	Effect of Severe Renal Impairment on Dordaviprone (ONC201) Pharmacokinetics Drugs in R&D ·Shamia L. Faison, Joëlle Batonga, Thangam Arumugham, Angela Bartkus, Marion E. Morrison, Mark J. Mullin, Tim Tippin, Odin Naderer	2025	1

About Marion E. Morrison

Marion E. Morrison is a scholar working on Epidemiology, Oncology, Rheumatology, Genetics and Infectious Diseases, having authored 16 papers that have together received 526 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Metabolism and Genetic Disorders (2 papers), Cancer therapeutics and mechanisms (2 papers), Polyomavirus and related diseases (2 papers), Folate and B Vitamins Research (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Virology (143 citations), Epidemiology (356 citations), Infectious Diseases (122 citations), Genetics (134 citations) and Parasitology (29 citations). Marion E. Morrison has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Thomas M. Brundage, Greg Chittick, W. Garrett Nichols, Roy F. Chemaly, Herve Momméja-Marin, Michael Boeckh, Tsiporah B. Shore, Timothy K. Tippin, Francisco M. Marty and Genovefa A. Papanicolaou. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Open Forum Infectious Diseases, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Therapeutic Drug Monitoring.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact